| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
310,240,000 |
| Market
Cap: |
6.73(B) |
| Last
Volume: |
3,013,019 |
Avg
Vol: |
2,434,266 |
| 52
Week Range: |
$18.78 - $24.13 |
|
| Level
I Sector: |
Industrials |
| Level
II Sector: |
Diversified Services |
| Level
III Sector: |
Research Services |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 17.5 |
| Insider 6 Months : 18.9 |
| Insider 3/6 Months : 36.8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Exelixis is an oncology-focused biotechnology company that engages in the discovery, development and commercialization of new medicines for cancers. Co.'s products include: CABOMETYX® (cabozantinib) tablets approved for renal cell carcinoma, and for previously treated hepatocellular carcinoma; and COMETRIQ® (cabozantinib) capsules approved for progressive, metastatic medullary thyroid cancer. The other products are: COTELLIC® (cobimetinib), an inhibitor of MEK approved as part of a combination regimen to treat forms of melanoma; and MINNEBRO® (esaxerenone), an oral, non-steroidal, selective blocker of the mineralocorticoid receptor approved for the treatment of hypertension in Japan.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
425,000 |
615,000 |
735,409 |
735,409 |
| Total Buy Value |
$8,733,955 |
$12,666,689 |
$15,268,727 |
$15,268,727 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
2 |
3 |
4 |
4 |
| Total Shares Sold |
80,531 |
241,700 |
593,372 |
1,012,962 |
| Total Sell Value |
$1,755,807 |
$5,376,989 |
$12,725,795 |
$20,083,859 |
| Total People Sold |
5 |
7 |
9 |
12 |
| Total Sell Transactions |
5 |
10 |
16 |
27 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Morrissey Michael M |
President and CEO |
• • – |
2020-04-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
93,640 |
600,761 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
93,640 |
85,985 |
|
- |
|
| Scangos George A |
Director |
– • – |
2020-04-24 |
4 |
AS |
$26.24 |
$393,600 |
D/D |
(15,000) |
738,031 |
|
-21% |
|
| Scangos George A |
Director |
– • – |
2020-04-23 |
4 |
AS |
$25.68 |
$2,598,635 |
D/D |
(100,000) |
753,031 |
|
-17% |
|
| Haley Patrick J. |
EVP, Commercial |
• – – |
2020-04-23 |
4 |
AS |
$26.00 |
$130,000 |
D/D |
(5,000) |
116,873 |
|
-17% |
|
| Haley Patrick J. |
EVP, Commercial |
• – – |
2020-04-23 |
4 |
OE |
$1.70 |
$8,500 |
D/D |
5,000 |
121,873 |
|
- |
|
| Schwab Gisela Md |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-04-23 |
4 |
AS |
$26.00 |
$2,600,000 |
D/D |
(100,000) |
325,122 |
|
-17% |
|
| Schwab Gisela Md |
Pres, Prod Dev & Med Aff & CMO |
• – – |
2020-04-23 |
4 |
OE |
$1.70 |
$170,000 |
D/D |
100,000 |
425,122 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-23 |
4 |
D |
$26.37 |
$4,123,213 |
D/D |
(156,360) |
179,625 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-23 |
4 |
OE |
$5.51 |
$1,377,500 |
D/D |
250,000 |
335,985 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
80,799 |
507,121 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
80,799 |
85,985 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-22 |
4 |
GA |
$0.00 |
$0 |
I/I |
87,079 |
426,322 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
87,079 |
166,784 |
|
- |
|
| Scangos George A |
Director |
– • – |
2020-04-22 |
4 |
AS |
$25.05 |
$105,210 |
D/D |
(4,200) |
853,031 |
|
-13% |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-21 |
4 |
D |
$24.56 |
$3,418,777 |
D/D |
(139,201) |
253,863 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-21 |
4 |
OE |
$5.51 |
$1,212,200 |
D/D |
220,000 |
393,064 |
|
- |
|
| Scangos George A |
Director |
– • – |
2020-04-21 |
4 |
AS |
$25.04 |
$145,232 |
D/D |
(5,800) |
857,231 |
|
-10% |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-20 |
4 |
D |
$23.58 |
$3,605,877 |
D/D |
(152,921) |
173,064 |
|
- |
|
| Morrissey Michael M |
President and CEO |
• • – |
2020-04-20 |
4 |
OE |
$5.51 |
$1,322,400 |
D/D |
240,000 |
325,985 |
|
- |
|
| Scangos George A |
Director |
– • – |
2020-04-20 |
4 |
AS |
$23.39 |
$1,194,637 |
D/D |
(50,000) |
863,031 |
|
-8% |
|
| Haley Patrick J. |
EVP, Commercial |
• – – |
2020-04-20 |
4 |
AS |
$24.00 |
$120,000 |
D/D |
(5,000) |
116,873 |
|
-8% |
|
| Haley Patrick J. |
EVP, Commercial |
• – – |
2020-04-20 |
4 |
OE |
$1.70 |
$8,500 |
D/D |
5,000 |
121,873 |
|
- |
|
| Scangos George A |
Director |
– • – |
2020-04-15 |
4 |
AS |
$18.31 |
$457,750 |
D/D |
(25,000) |
913,031 |
|
19% |
|
| Scangos George A |
Director |
– • – |
2020-04-08 |
4 |
AS |
$18.35 |
$129,643 |
D/D |
(7,065) |
938,031 |
|
21% |
|
985 Records found
|
|
Page 19 of 40 |
|
|
0.91 (4.38%) 
